Chargement en cours...
A gene signature predicts response to neoadjuvant chemotherapy in triple-negative breast cancer patients
Triple-negative breast cancer (TNBC) accounts for approximately 15% of all breast cancer cases. TNBC is highly aggressive and associated with poor prognosis. The present study aimed to compare gene expression between TNBC patients with pathological complete response (pCR) and those with not complete...
Enregistré dans:
| Publié dans: | Biosci Rep |
|---|---|
| Auteurs principaux: | , , |
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
Portland Press Ltd.
2019
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6509059/ https://ncbi.nlm.nih.gov/pubmed/30988073 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1042/BSR20190414 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|